These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27236681)

  • 1. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.
    Radrizzani M; Soncin S; Lo Cicero V; Andriolo G; Bolis S; Turchetto L
    Methods Mol Biol; 2016; 1416():313-37. PubMed ID: 27236681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Validation Strategy.
    Radrizzani M; Soncin S; Bolis S; Lo Cicero V; Andriolo G; Turchetto L
    Methods Mol Biol; 2016; 1416():339-56. PubMed ID: 27236682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GMP-Grade Methods for Cardiac Progenitor Cells: Cell Bank Production and Quality Control.
    Andriolo G; Provasi E; Brambilla A; Lo Cicero V; Soncin S; Barile L; Turchetto L; Radrizzani M
    Methods Mol Biol; 2021; 2286():131-166. PubMed ID: 33381854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-scale expansion of mesenchymal stromal cells: a large banking experience.
    Lechanteur C; Briquet A; Giet O; Delloye O; Baudoux E; Beguin Y
    J Transl Med; 2016 May; 14(1):145. PubMed ID: 27207011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells.
    Codinach M; Blanco M; Ortega I; Lloret M; Reales L; Coca MI; Torrents S; Doral M; Oliver-Vila I; Requena-Montero M; Vives J; Garcia-López J
    Cytotherapy; 2016 Sep; 18(9):1197-208. PubMed ID: 27424149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion.
    Grisendi G; Annerén C; Cafarelli L; Sternieri R; Veronesi E; Cervo GL; Luminari S; Maur M; Frassoldati A; Palazzi G; Otsuru S; Bambi F; Paolucci P; Pierfranco C; Horwitz E; Dominici M
    Cytotherapy; 2010 Jul; 12(4):466-77. PubMed ID: 20353309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems.
    Fernandes-Platzgummer A; Carmelo JG; da Silva CL; Cabral JM
    Methods Mol Biol; 2016; 1416():375-88. PubMed ID: 27236684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
    Wuchter P; Bieback K; Schrezenmeier H; Bornhäuser M; Müller LP; Bönig H; Wagner W; Meisel R; Pavel P; Tonn T; Lang P; Müller I; Renner M; Malcherek G; Saffrich R; Buss EC; Horn P; Rojewski M; Schmitt A; Ho AD; Sanzenbacher R; Schmitt M
    Cytotherapy; 2015 Feb; 17(2):128-39. PubMed ID: 24856898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.
    Martins JP; Santos JM; de Almeida JM; Filipe MA; de Almeida MV; Almeida SC; Água-Doce A; Varela A; Gilljam M; Stellan B; Pohl S; Dittmar K; Lindenmaier W; Alici E; Graça L; Cruz PE; Cruz HJ; Bárcia RN
    Stem Cell Res Ther; 2014 Jan; 5(1):9. PubMed ID: 24438697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical grade expansion of MSCs.
    Capelli C; Pedrini O; Valgardsdottir R; Da Roit F; Golay J; Introna M
    Immunol Lett; 2015 Dec; 168(2):222-7. PubMed ID: 26092523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GMP-Compliant Expansion of Clinical-Grade Human Mesenchymal Stromal/Stem Cells Using a Closed Hollow Fiber Bioreactor.
    Barckhausen C; Rice B; Baila S; Sensebé L; Schrezenmeier H; Nold P; Hackstein H; Rojewski MT
    Methods Mol Biol; 2016; 1416():389-412. PubMed ID: 27236685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice.
    Soncin S; Lo Cicero V; Astori G; Soldati G; Gola M; Sürder D; Moccetti T
    J Transl Med; 2009 Sep; 7():78. PubMed ID: 19737416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryopreservation does not alter main characteristics of Good Manufacturing Process-grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation.
    Luetzkendorf J; Nerger K; Hering J; Moegel A; Hoffmann K; Hoefers C; Mueller-Tidow C; Mueller LP
    Cytotherapy; 2015 Feb; 17(2):186-98. PubMed ID: 25593077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard operating procedure for the good manufacturing practice-compliant production of human bone marrow mesenchymal stem cells.
    Roseti L; Serra M; Bassi A
    Methods Mol Biol; 2015; 1283():171-86. PubMed ID: 25092055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
    Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
    Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans.
    Labedz-Maslowska A; Szkaradek A; Mierzwinski T; Madeja Z; Zuba-Surma E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of starting material (fresh versus cryopreserved marrow) on mesenchymal stem cell culture.
    Kaplan A; Sackett K; Sumstad D; Kadidlo D; McKenna DH
    Transfusion; 2017 Sep; 57(9):2216-2219. PubMed ID: 28653392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process.
    Lechanteur C; Briquet A; Bettonville V; Baudoux E; Beguin Y
    Cells; 2021 May; 10(6):. PubMed ID: 34073206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and Manufacture of Clinical-Grade Bone Marrow-Derived Human Mesenchymal Stromal Cells.
    Miller RP; Hanley PJ
    Methods Mol Biol; 2016; 1416():301-12. PubMed ID: 27236680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production.
    Camilleri ET; Gustafson MP; Dudakovic A; Riester SM; Garces CG; Paradise CR; Takai H; Karperien M; Cool S; Sampen HJ; Larson AN; Qu W; Smith J; Dietz AB; van Wijnen AJ
    Stem Cell Res Ther; 2016 Aug; 7(1):107. PubMed ID: 27515308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.